R.I.P. MRSA

By John Connole
Thursday, 04 October, 2012



SAFE AND EFFECTIVE INFECTION CONTROL WITH AUSTRALIAN COMPANY


The World Health Organisation has called for urgent action on the spread of MRSA and other antibiotic resistant strains. These ‘superbugs’ are commonly associated with increased patient morbidity and mortality and increased costs of health care.


MRSA is usually transmitted by direct skin-to-skin contact or contact with shared items or surfaces that have come into contact with someone else’s MRSA infection. Therefore, it is imperative to practice both good personal hygiene and disinfection of items and surfaces with appropriate products to kill the MRSA virus – including sodium hypochlorite, more commonly known as bleach.


Studies have shown that MRSA rates in hospitals have been significantly reduced due to the implementation of sodium hypochlorite as part of the infection control regime. Further, one study shows that stopping sodium hypochlorite environmental disinfection was strongly associated with an increase in clinical MRSA cases. Sodium hypochlorite is also an effective antimicrobial against microorganisms, bacteria, fungi, spores and virus’s arising from blood and body fluid spills.


Australian company Eucalip Bio-Chemical Group Pty Ltd has innovatively manufactured a product, which is conveniently packaged in a sachet and ideal for everyday use as required – simply add water and safely and effectively sanitise your area. There are two hospital grade strengths in the Det-Sol range. Det-Sol 500 is used for sanitising hard surface areas, such as areas of food preparation and areas where general infection control is needed. Det-Sol 5000 is used in “dirty areas” where blood and body fluid spills may occur and a higher concentration of disinfection is required. Det Sol is currently used by major hospitals, institutions, pathology and military nationally. To add Det-Sol to your infection control program or for more information, go to www.eucalipgroup.com.


References


1. Gorwitz RJ et al. Journal of Infectious Diseases. 2008:197:1226-34.).


2. World Health Organization Department of Communicable Disease Surveillance and Response. WHO global strategy for containment of antimicrobial resistance. Geneva: WHO, 2001.http://www.who.int/csr/resources/publications/drugresist/WHO_CDS_CSR_DRS_2001_2_ EN/en/ (accessed oct 2011).

Related Articles

The impact of COVID-19 on Indigenous Australians

A report led by the University of Western Australia reveals that the pandemic has put many...

Renowned rehab program for PD arrives in Sydney

The PD Warrior program has arrived in Sydney's north-west, with the potential to improve the...

Call for palliative care overhaul

Palliative Care Australia has released a report calling for an overhaul of the palliative care...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd